Please assess the completion status of the following clinical trial:

Trial Title: Allogeneic Stem Cell Transplantation in Pediatric Patients With Malignant and Non-malignant High-risk Diseases

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients aged 0 to 30 years~* Written informed consent from patient and/or parents or guardian~* Patients with Karnofsky Index \> 60%~* Malignant disease:~  * acute lymphoblastic leukemia~ * acute myeloid leukemia~ * myelodysplastic syndrome~ * chronic myeloid leukemia according to the standard indications~ * solid tumors (e.g. neuroblastoma recurrence, soft-tissue sarcoma, Ewing's sarcoma, osteosarcoma, hepatoblastoma)~    . Non malignant disease:~ * acquired anemias (e.g. severe aplastic anemia, particularly severe Evans syndrome)~ * congenital anemias (e.g. thalassemia and sickle cell anemia)~* Women reliable contraception method when appropriate~Exclusion Criteria:~* Participation in other clinical trials~* Patients, parents, or guardians unable to understand the nature, the importance and the implications of the procedure~* Pregnant or nursing women~* Patients who underwent a stem cell transplantation in the last 250 days~* Patients with kidney, heart or liver insufficiency

- Gender: ALL
- Minimum Age: None
- Maximum Age: 30 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).